Sponsor

Department of Health and Human Services

Clinical research sponsor

Published trials37
Recruiting shown3
Roles1
SourceClinicalTrials.gov

Clinical trials

37 shown
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan AntibodiesNCT07569029 · collaborator · 2026-09-15
RECRUITING
A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1NCT07390955 · collaborator · 2026-03-19
RECRUITING
OASIS: Peer Support for T2DM in Appalachia (Peer Participant)NCT06336122 · collaborator · 2023-11-20
RECRUITING
A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIVNCT06919016 · collaborator · 2025-08-06
ACTIVE_NOT_RECRUITING
A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIVNCT06905275 · collaborator · 2025-07-07
SUSPENDED
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIVNCT06812494 · collaborator · 2025-03-07
ACTIVE_NOT_RECRUITING
A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIVNCT06557785 · collaborator · 2024-11-25
ACTIVE_NOT_RECRUITING
A Clinical Trial in Adult Participants Without HIV and in Overall Good Health to Evaluate the Safety and Immunogenicity of CD4BS CH505M5 Pr-NP1 Followed by CH505 TF chTrimer Boost Both Adjuvanted With Either Lipid Nanoparticles (LNPs) or 3M-052-AF + AlumNCT06267872 · collaborator · 2024-10-07
WITHDRAWN
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIVNCT06033209 · collaborator · 2023-11-27
COMPLETED
Peer Support for Patients With Diabetic Foot UlcersNCT06004219 · collaborator · 2023-11-21
UNKNOWN
Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIVNCT05781542 · collaborator · 2023-04-10
COMPLETED
A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral TherapyNCT05261191 · collaborator · 2022-09-26
COMPLETED
Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIVNCT05471076 · collaborator · 2022-08-22
COMPLETED
A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy AdultsNCT05470400 · collaborator · 2022-08-15
TERMINATED
A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult ParticipantsNCT05217641 · collaborator · 2022-02-11
ACTIVE_NOT_RECRUITING
Lifestyle Patterns and Glycemic ControlNCT05224986 · collaborator · 2022-01-19
ACTIVE_NOT_RECRUITING
Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult.NCT05182125 · collaborator · 2021-11-25
COMPLETED
A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult ParticipantsNCT05184452 · collaborator · 2021-11-15
COMPLETED
Respiratory Infection MonitoringNCT04362631 · collaborator · 2020-04-24
COMPLETED
Families Coping Together With Alzheimer's DiseaseNCT04642885 · collaborator · 2019-06-30
COMPLETED
South Texas Early Prevention Studies PreKNCT05501392 · collaborator · 2018-09-28
COMPLETED
Blood Glucose Monitoring in Electronic Health RecordsNCT03542487 · collaborator · 2018-05-01
COMPLETED
Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve StimulationNCT03359902 · collaborator · 2018-01-01
COMPLETED
Functional Imaging in Lung SBRTNCT03121300 · collaborator · 2017-02-06
COMPLETED
ABC Brain Games Self-Regulation InterventionNCT03060863 · collaborator · 2015-09-01
COMPLETED
Randomized Study of Daytime vs. Delayed Eating: Effect on Weight and MetabolismNCT04414644 · collaborator · 2014-10-08
COMPLETED
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic AsthmaNCT02022761 · collaborator · 2013-10-01
COMPLETED
Coalition for a Healthier Community-Utah Women and Girls - Phase II (UWAG-II)NCT02470156 · collaborator · 2012-05-01
COMPLETED
Diabetes-Depression Care-management Adoption TrialNCT01781013 · collaborator · 2010-06-01
COMPLETED
Healthy Babies Through Infant Centered FeedingNCT01816516 · collaborator · 2010-02-01
COMPLETED
School Centered Telemedicine Program for Children With Type 1 Diabetes MellitusNCT00566475 · collaborator · 2007-01-01
COMPLETED
All About Youth: Evaluation of Sexual Risk Avoidance and Risk Reduction Programs for Middle School StudentsNCT00167505 · collaborator · 2006-09-01
COMPLETED
International HIV Antiretroviral Adherence, Resistance and SurvivalNCT01596322 · collaborator · 2004-09-01
COMPLETED
Asthma in a Decentralized Patient Population: Is Traditional Disease Management Enough?NCT00124085 · collaborator · 2003-10-01
COMPLETED
Healing Touch, Quality of Life, and Immunity During Breast Cancer TreatmentNCT00565305 · collaborator · 2003-07-01
COMPLETED
Self Monitoring of Blood Glucose With Finger Tip vs. Alternate Site Sampling: Effect on Long Term Glycemic ControlNCT00207207 · collaborator · 2003-07-01
COMPLETED
Percutaneous Removal and Margin Ablation for Breast CancerNCT00574301 · collaborator · 2002-03-01
COMPLETED

Sponsor roles

collaborator37

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.